|
1
|
Guthrie D and Gibson AL: Doxorubicin
cardiotoxicity: Possible role of digoxin in its prevention. BMJ.
2:1447–1449. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Horwitz SB, Lothstein L, Manfredi JJ,
Mellado W, Parness J, Roy SN, Schiff PB, Sorbara L and Zeheb R:
Taxol: Mechanisms of action and resistance. Ann NY Acad Sci.
466:733–744. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peterson DE and Sonis ST: Oral
complications of cancer chemotherapy: Present status and future
studies. Cancer Treat Rep. 66:1251–1256. 1982.PubMed/NCBI
|
|
4
|
Erber R, Gluz O, Brünner N, Kreipe HH,
Pelz E, Kates R, Bartels A, Huober J, Mohrmann S, Moustafa Z, et
al: Predictive role of HER2/neu, topoisomerase-II-α, and tissue
inhibitor of metalloproteinases (TIMP-1) for response to adjuvant
taxane-based chemotherapy in patients with intermediate-risk breast
cancer: Results from the WSG-AGO EC-Doc trial. Breast Cancer Res
Treat. 150:279–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seely D, Wu P, Fritz H, Kennedy DA, Tsui
T, Seely AJ and Mills E: Melatonin as adjuvant cancer care with and
without chemotherapy: A systematic review and meta-analysis of
randomized trials. Integr Cancer Ther. 11:293–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lecumberri E, Dupertuis YM, Miralbell R
and Pichard C: Green tea polyphenol epigallocatechin-3-gallate
(EGCG) as adjuvant in cancer therapy. Clin Nutr. 32:894–903. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo
N, Li XK and Tang W: Chinese herbal medicines as adjuvant treatment
during chemo- or radio-therapy for cancer. Biosci Trends.
4:297–307. 2010.PubMed/NCBI
|
|
8
|
Wang CY, Bai XY and Wang CH: Traditional
Chinese medicine: A treasured natural resource of anticancer drug
research and development. Am J Chin Med. 42:543–559. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chatterjee K, Zhang J, Honbo N and
Karliner JS: Doxorubicin cardiomyopathy. Cardiology. 115:155–162.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bandyopadhyay A, Wang L, Agyin J, Tang Y,
Lin S, Yeh IT, De K and Sun LZ: Doxorubicin in combination with a
small TGFβ inhibitor: A potential novel therapy for metastatic
breast cancer in mouse models. PLoS One. 5:e103652010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang S, Wang L, Chen M and Wang Y:
Gambogic acid sensitizes resistant breast cancer cells to
doxorubicin through inhibiting P-glycoprotein and suppressing
survivin expression. Chem Biol Interact. 235:76–84. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thandavarayan RA, Giridharan VV, Arumugam
S, Suzuki K, Ko KM, Krishnamurthy P, Watanabe K and Konishi T:
Schisandrin B prevents doxorubicin induced cardiac dysfunction by
modulation of DNA damage, oxidative stress and inflammation through
inhibition of MAPK/p53 signaling. PLoS One. 10:e01192142015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ashraf K, Mujeeb M, Ahmad A, Ahmad N and
Amir M: Determination of curcuminoids in Curcuma longa Linn.
by UPLC/Q-TOF-MS: An application in turmeric cultivation. J
Chromatogr Sci. 53:1346–1352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang FQ, Wang YT and Li SP: Simultaneous
determination of 11 characteristic components in three species of
Curcuma rhizomes using pressurized liquid extraction and
high-performance liquid chromatography. J Chromatogr A.
1134:226–231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ray S, Chattopadhyay N, Mitra A, Siddiqi M
and Chatterjee A: Curcumin exhibits antimetastatic properties by
modulating integrin receptors, collagenase activity, and expression
of Nm23 and E-cadherin. J Environ Pathol Toxicol Oncol. 22:49–58.
2003.PubMed/NCBI
|
|
16
|
Leu TH, Su SL, Chuang YC and Maa MC:
Direct inhibitory effect of curcumin on Src and focal adhesion
kinase activity. Biochem Pharmacol. 66:2323–2331. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin ML, Lu YC, Chen HY, Lee CC, Chung JG
and Chen SS: Suppressing the formation of lipid raft-associated
Rac1/PI3K/Akt signaling complexes by curcumin inhibits
SDF-1α-induced invasion of human esophageal carcinoma cells. Mol
Carcinog. 53:360–379. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen WC, Lai YA, Lin YC, Ma JW, Huang LF,
Yang NS, Ho CT, Kuo SC and Way TD: Curcumin suppresses
doxorubicin-induced epithelial-mesenchymal transition via the
inhibition of TGF-β and PI3K/AKT signaling pathways in
triple-negative breast cancer cells. J Agric Food Chem.
61:11817–11824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong JH, Lee G and Choi HY: Effect of
curcumin on the interaction between androgen receptor and
Wnt/β-catenin in LNCaP xenografts. Korean J Urol. 56:656–665. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Zhang Y and Li Y: β-elemene
decreases cell invasion by upregulating E-cadherin expression in
MCF-7 human breast cancer cells. Oncol Rep. 30:745–750.
2013.PubMed/NCBI
|
|
21
|
Shi H, Liu L, Liu LM, Geng J and Chen L:
Inhibition of tumor growth by β-elemene through downregulation of
the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine
intraocular melanoma model. Melanoma Res. 25:15–21. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong Z, Dang Y, Yuan X, Guo W, Li Y, Tan
W, Cui J, Lu J, Zhang Q, Chen X, et al: Furanodiene, a natural
product, inhibits breast cancer growth both in vitro and in vivo.
Cell Physiol Biochem. 30:778–790. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W,
Chen XP, Cui L, Wu T and Wang YT: Anti-angiogenic effect of
furanodiene on HUVECs in vitro and on zebrafish in vivo. J
Ethnopharmacol. 141:721–727. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhong Z, Tan W, Chen X and Wang Y:
Furanodiene, a natural small molecule suppresses metastatic breast
cancer cell migration and invasion in vitro. Eur J Pharmacol.
737:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong ZF, Li YB, Wang SP, Tan W, Chen XP,
Chen MW and Wang YT: Furanodiene enhances tamoxifen-induced growth
inhibitory activity of ERa-positive breast cancer cells in a PPARγ
independent manner. J Cell Biochem. 113:2643–2651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li T, Xu XH, Tang ZH, Wang YF, Leung CH,
Ma DL, Chen XP, Wang YT, Chen Y and Lu JJ: Platycodin D induces
apoptosis and triggers ERK- and JNK-mediated autophagy in human
hepatocellular carcinoma BEL-7402 cells. Acta Pharmacol Sin.
36:1503–1513. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhong Z, Liu LJ, Dong ZQ, Lu L, Wang M,
Leung CH, Ma DL and Wang Y: Structure-based discovery of an
immunomodulatory inhibitor of TLR1-TLR2 heterodimerization from a
natural product-like database. Chem Commun. 51:11178–11181. 2015.
View Article : Google Scholar
|
|
28
|
Gao JL, Shi JM, He K, Zhang QW, Li SP, Lee
SM and Wang YT: Yanhusuo extract inhibits metastasis of breast
cancer cells by modulating mitogen-activated protein kinase
signaling pathways. Oncol Rep. 20:819–824. 2008.PubMed/NCBI
|
|
29
|
Saraswati S, Alhaider AA and Agrawal SS:
Punarnavine, an alkaloid from Boerhaavia diffusa exhibits
anti-angiogenic activity via downregulation of VEGF in vitro and in
vivo. Chem Biol Interact. 206:204–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miltenburg NC and Boogerd W:
Chemotherapy-induced neuropathy: A comprehensive survey. Cancer
Treat Rev. 40:872–882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paus R, Haslam IS, Sharov AA and
Botchkarev VA: Pathobiology of chemotherapy-induced hair loss.
Lancet Oncol. 14:e50–e59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wardill HR, Bowen JM and Gibson RJ:
Chemotherapy-induced gut toxicity: Are alterations to intestinal
tight junctions pivotal? Cancer Chemother Pharmacol. 70:627–635.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Daenen LG, Roodhart JM, van Amersfoort M,
Dehnad M, Roessingh W, Ulfman LH, Derksen PW and Voest EE:
Chemo-therapy enhances metastasis formation via VEGFR-1-expressing
endothelial cells. Cancer Res. 71:6976–6985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ran S: The role of TLR4 in
chemotherapy-driven metastasis. Cancer Res. 75:2405–2410. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park SI, Liao J, Berry JE, Li X, Koh AJ,
Michalski ME, Eber MR, Soki FN, Sadler D, Sud S, et al:
Cyclophosphamide creates a receptive microenvironment for prostate
cancer skeletal metastasis. Cancer Res. 72:2522–2532. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vyas D, Laput G and Vyas AK:
Chemotherapy-enhanced inflammation may lead to the failure of
therapy and metastasis. Onco Targets Ther. 7:1015–1023. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiong W, Ren ZG, Qiu SJ, Sun HC, Wang L,
Liu BB, Li QS, Zhang W, Zhu XD, Liu L, et al: Residual
hepatocellular carcinoma after oxaliplatin treatment has increased
metastatic potential in a nude mouse model and is attenuated by
Songyou Yin. BMC Cancer. 10:2192010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Biswas S, Guix M, Rinehart C, Dugger TC,
Chytil A, Moses HL, Freeman ML and Arteaga CL: Inhibition of TGF-β
with neutralizing antibodies prevents radiation-induced
acceleration of metastatic cancer progression. J Clin Invest.
117:1305–1313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pichot CS, Hartig SM, Xia L, Arvanitis C,
Monisvais D, Lee FY, Frost JA and Corey SJ: Dasatinib synergizes
with doxorubicin to block growth, migration, and invasion of breast
cancer cells. Br J Cancer. 101:38–47. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim S, Harris M and Varner JA: Regulation
of integrin α vβ 3-mediated endothelial cell migration and
angiogenesis by integrin α5β1 and protein kinase A. J Biol Chem.
275:33920–33928. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Parsons JT, Martin KH, Slack JK, Taylor JM
and Weed SA: Focal adhesion kinase: A regulator of focal adhesion
dynamics and cell movement. Oncogene. 19:5606–5613. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen HC, Appeddu PA, Isoda H and Guan JL:
Phosphorylation of tyrosine 397 in focal adhesion kinase is
required for binding phosphatidylinositol 3-kinase. J Biol Chem.
271:26329–26334. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Webb DJ, Donais K, Whitmore LA, Thomas SM,
Turner CE, Parsons JT and Horwitz AF: FAK-Src signalling through
paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell
Biol. 6:154–161. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Thant AA, Nawa A, Kikkawa F, Ichigotani Y,
Zhang Y, Sein TT, Amin AR and Hamaguchi M: Fibronectin activates
matrix metalloproteinase-9 secretion via the MEK1-MAPK and the
PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis.
18:423–428. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Woodfield RJ, Hodgkin MN, Akhtar N, Morse
MA, Fuller KJ, Saqib K, Thompson NT and Wakelam MJ: The p85 subunit
of phosphoinositide 3-kinase is associated with β-catenin in the
cadherin-based adhesion complex. Biochem J. 360:335–344. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Vu TH, Shipley JM, Bergers G, Berger JE,
Helms JA, Hanahan D, Shapiro SD, Senior RM and Werb Z:
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis
and apoptosis of hypertrophic chondrocytes. Cell. 93:411–422. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bartsch JE, Staren ED and Appert HE:
Matrix metalloproteinase expression in breast cancer. J Surg Res.
110:383–392. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Van Keymeulen A, Wong K, Knight ZA,
Govaerts C, Hahn KM, Shokat KM and Bourne HR: To stabilize
neutrophil polarity, PIP3 and Cdc42 augment RhoA activity at the
back as well as signals at the front. J Cell Biol. 174:437–445.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nobes CD and Hall A: Rho, rac and cdc42
GTPases: Regulators of actin structures, cell adhesion and
motility. Biochem Soc Trans. 23:456–459. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Carlier MF, Ducruix A and Pantaloni D:
Signalling to actin: The Cdc42-N-WASP-Arp2/3 connection. Chem Biol.
6:R235–R240. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rohatgi R, Ma L, Miki H, Lopez M,
Kirchhausen T, Takenawa T and Kirschner MW: The interaction between
N-WASP and the Arp2/3 complex links Cdc42-dependent signals to
actin assembly. Cell. 97:221–231. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yamazaki D, Kurisu S and Takenawa T:
Regulation of cancer cell motility through actin reorganization.
Cancer Sci. 96:379–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Westermann S and Weber K:
Post-translational modifications regulate microtubule function. Nat
Rev Mol Cell Biol. 4:938–947. 2003. View Article : Google Scholar : PubMed/NCBI
|
